MA42829A - Compositions dérivées de placenta et procédés pour les produire - Google Patents

Compositions dérivées de placenta et procédés pour les produire

Info

Publication number
MA42829A
MA42829A MA042829A MA42829A MA42829A MA 42829 A MA42829 A MA 42829A MA 042829 A MA042829 A MA 042829A MA 42829 A MA42829 A MA 42829A MA 42829 A MA42829 A MA 42829A
Authority
MA
Morocco
Prior art keywords
placenta
processes
producing
compositions derived
compositions
Prior art date
Application number
MA042829A
Other languages
English (en)
Inventor
Richard A Berg
John Daniel
Sarah Griffiths
Original Assignee
Stimlabs Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stimlabs Llc filed Critical Stimlabs Llc
Publication of MA42829A publication Critical patent/MA42829A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
    • C12N2533/92—Amnion; Decellularised dermis or mucosa

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Botany (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Materials Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
MA042829A 2015-09-17 2016-09-16 Compositions dérivées de placenta et procédés pour les produire MA42829A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562220227P 2015-09-17 2015-09-17
US201662334440P 2016-05-10 2016-05-10

Publications (1)

Publication Number Publication Date
MA42829A true MA42829A (fr) 2021-04-14

Family

ID=57068210

Family Applications (1)

Application Number Title Priority Date Filing Date
MA042829A MA42829A (fr) 2015-09-17 2016-09-16 Compositions dérivées de placenta et procédés pour les produire

Country Status (5)

Country Link
US (4) US11413372B2 (fr)
EP (3) EP3349813B1 (fr)
AU (3) AU2016324167C1 (fr)
MA (1) MA42829A (fr)
WO (1) WO2017049215A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3804774A1 (fr) 2015-04-09 2021-04-14 3M Innovative Properties Co. Système pour le prélèvement de greffons de peau
EP3349812B1 (fr) 2015-09-17 2021-01-06 Stimlabs LLC Compositions dérivées de placenta et procédés pour les produire
EP3349813B1 (fr) 2015-09-17 2021-09-01 Stimlabs LLC Compositions dérivées de placenta et procédés pour les produire
EP3370630B1 (fr) 2015-11-03 2021-06-16 3M Innovative Properties Company Dispositif de création d'une feuille de greffe épidermique
WO2017112934A1 (fr) * 2015-12-23 2017-06-29 Lifenet Health Membrane placentaire décellularisée et ses procédés de préparation et d'utilisation
CA3032160C (fr) 2016-08-24 2024-05-28 Arthrex, Inc. Tissu hybride a utiliser dans la reparation, la reconstruction ou la regeneration de suite a des processus degeneratifs ou blessures musculosquelettiques
US20200315853A1 (en) * 2017-12-20 2020-10-08 Kci Licensing, Inc. Wound dressing for the harvesting of superficial epidermal grafts
US11154641B2 (en) 2017-12-22 2021-10-26 Stimlabs Llc Translucent, dehydrated placental tissue and methods of producing and using the same
US11511017B2 (en) 2019-03-12 2022-11-29 Arthrex, Inc. Ligament reconstruction
AU2020245632A1 (en) * 2019-03-28 2021-09-30 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Method of treating or preventing hernia formation
CN110404119B (zh) * 2019-08-29 2023-04-07 上海越增生物科技有限公司 羊膜组织工程去免疫原皮肤支架的制备方法
US11944718B1 (en) 2022-05-11 2024-04-02 Healthtech Solutions, Inc. Compositions and manufacture of allograft tissue
WO2025188820A1 (fr) * 2024-03-05 2025-09-12 Gi Surgical Innovations, Inc. Timbre bioadhésif

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001994A (en) 1974-08-30 1977-01-11 Schlegel Corporation Glazing device
WO2004028584A1 (fr) 2002-09-30 2004-04-08 Bioland Ltd. Substitut dermique compose d'amnios et d'un polymere biodegradable, procede de preparation et utilisation de ce substitut
US20050107876A1 (en) 2002-09-30 2005-05-19 Kim Ki-Ho Dermal substitute consisting of amnion and biodegradable polymer, the preparation method and the use thereof
EP1796693A2 (fr) 2004-08-26 2007-06-20 Chandrashekhar P. Pathak Compositions tissulaires implantables et procede
US8231908B2 (en) 2005-07-25 2012-07-31 Arblast Co., Ltd. Sheet-like composition
WO2007023750A1 (fr) 2005-08-26 2007-03-01 National University Corporation University Of Toyama Amnion seche et procede de sechage de l’amnion
WO2007114809A1 (fr) 2006-03-30 2007-10-11 Medtreo, Llc Dispositif medical de perforation de membrane biologique
US8372437B2 (en) 2006-08-17 2013-02-12 Mimedx Group, Inc. Placental tissue grafts
EP2133105A4 (fr) 2007-02-23 2012-12-19 Nat Univ Corp Univ Toyama Membrane médicale de remplacement, utilisation de celle-ci et procédé pour la réparation d'un tissu de membrane dans un corps vivant
EP4559488A3 (fr) 2007-09-07 2025-08-13 MiMedx Group, Inc. Greffons de tissu placentaire et procédés améliorés de préparation et d'utilisation de ceux-ci
US9358320B2 (en) 2008-04-25 2016-06-07 Allosource Multi-layer tissue patches
CN102176881B (zh) 2008-10-10 2014-12-10 海斯特赛尔有限公司 来自人脐带的脐带胶质的新生物材料
KR101132625B1 (ko) 2010-02-03 2012-04-02 주식회사 바이오랜드 콘택트 렌즈 형태의 양막 드레싱의 제조 방법
US9433490B2 (en) 2010-12-22 2016-09-06 University Of Florida Research Foundation, Inc. Multilayered implant materials derived from amniotic membrane, methods of making the multilayered implant materials, and method of using multilayered implant materials
WO2012112410A2 (fr) 2011-02-14 2012-08-23 Mimedx Group Inc. Compositions micronisées de tissu placentaire, et méthodes de fabrication et d'utilisation de celles-ci
US9539104B2 (en) 2011-09-30 2017-01-10 NuTech Spine, Inc. Osteoconductive implants and methods of using same
US10517902B2 (en) 2011-09-30 2019-12-31 Prime Merger Sub, Llc Expandable amnion membrane for treating non-healing wounds
US20130136773A1 (en) 2011-09-30 2013-05-30 NuTech Spine, Inc. Expandable Placental Membrane and Methods of Making and Storing Same
US9486316B2 (en) 2011-09-30 2016-11-08 NuTech Spine, Inc. Osteoconductive implants and methods of using same
WO2013082158A1 (fr) 2011-12-02 2013-06-06 Mimedx Group Inc. Greffes de tissu déchiré et procédés de fabrication et d'utilisation de celles-ci
US9186382B2 (en) * 2011-12-02 2015-11-17 Mimedx Group, Inc. Placental tissue grafts produced by chemical dehydration/freeze-drying and methods for making and using the same
US8904664B2 (en) * 2012-08-15 2014-12-09 Mimedx Group, Inc. Dehydration device and methods for drying biological materials
US20140186461A1 (en) 2012-09-10 2014-07-03 Alpha Tissue, Inc. Human Amniotic Membrane Lyophilized Grafts
US10905800B1 (en) * 2013-01-29 2021-02-02 BioDlogics, LLC Ocular covering and method of use
JP7099822B2 (ja) * 2014-08-28 2022-07-12 ミメディクス グループ インコーポレイテッド コラーゲンで強化した組織移植片
AU2015350244B2 (en) 2014-11-17 2020-02-27 Mimedx Group, Inc. Fenestration kits for making fenestrated placental tissue allografts and methods of using the same
EP3349813B1 (fr) 2015-09-17 2021-09-01 Stimlabs LLC Compositions dérivées de placenta et procédés pour les produire
EP3349812B1 (fr) 2015-09-17 2021-01-06 Stimlabs LLC Compositions dérivées de placenta et procédés pour les produire
US20170086961A1 (en) 2015-09-25 2017-03-30 Vivex Biomedical, Inc. Structurally enhanced tissue graft
WO2017112934A1 (fr) 2015-12-23 2017-06-29 Lifenet Health Membrane placentaire décellularisée et ses procédés de préparation et d'utilisation

Also Published As

Publication number Publication date
AU2024202501A1 (en) 2024-05-09
US20250099648A1 (en) 2025-03-27
AU2016324167C1 (en) 2022-11-24
AU2021205013B2 (en) 2024-04-11
EP4378491A1 (fr) 2024-06-05
WO2017049215A1 (fr) 2017-03-23
AU2016324167A1 (en) 2018-04-26
US20180280572A1 (en) 2018-10-04
AU2021205013A1 (en) 2021-08-12
EP3998089A1 (fr) 2022-05-18
AU2016324167B2 (en) 2021-04-15
US20220331484A1 (en) 2022-10-20
US11413372B2 (en) 2022-08-16
EP3349813B1 (fr) 2021-09-01
EP3349813A1 (fr) 2018-07-25
US20230103744A1 (en) 2023-04-06
EP3998089B1 (fr) 2023-11-01

Similar Documents

Publication Publication Date Title
MA42829A (fr) Compositions dérivées de placenta et procédés pour les produire
EP3493827A4 (fr) Compositions et procédés pour immunothérapie
IL256295A (en) Anti-ntb-a antibodies and related compositions and methods
EP3827846C0 (fr) Compositions, combinaisons et procédés associés pour photoimmunothérapie
EP3362103C0 (fr) Compositions et procédés faisant appel à des néo-épitopes cancéreux viraux
EP3331571A4 (fr) Compositions et procédés pour traiter des infections virales
EP3430170A4 (fr) Procédés pour la caractérisation de génomes
EP3347458A4 (fr) Cochon multi-transgénique pour xénogreffe
SG10201603721TA (en) Anti-CTLA-4 Antibodies
EP3405577A4 (fr) Compositions et procédés pour inhiber le facteur d
DK3556775T3 (da) Anti-lag-3 antistoffer til behandling af hæmatologiske maligniteter
HUE059158T2 (hu) Eljárás pridopidin elõállítására
HUE069391T2 (hu) Antitest kompozíciók
FR3036518B1 (fr) Inversion pour contrainte tectonique
EP3696198A4 (fr) Composition de résine pour stéréolithographie
EP3494234A4 (fr) Procédés pour la caractérisation génomique
EP3519028A4 (fr) Étrier pour harnais
MA49610A (fr) Procédés et compositions pour améliorer la production de myéline fonctionnelle
EP3429690A4 (fr) Procédés pour moduler keap1
EP3393269A4 (fr) Compositions de protéines végétales fermentées procédés pour les produire
EP3400300A4 (fr) Procédés pour réduire l'expression de lrrk2
EP3265100A4 (fr) Procédés de préparation de fluorokétolides
EP3506748A4 (fr) Procédés améliorés pour la synthèse de perméthrine
EP3363288A4 (fr) Composition pour la destruction de microalgues ou de sphaerocarpus
EP3319930A4 (fr) Procédés et compositions pour la stabilisation de protéines